Disruptive technologies and competitive advantage of firms in dynamic markets

A fundamental problem in the field of management of technology is how firms develop and sustain disruptive technologies for competitive advantage in markets. The vast literature has analyzed several characteristics of disruptive innovations. However, the determinants are hardly known. The study here seems to show, in a market with high intensity of R&D investments (anticancer drugs), that the emergence of disruptive technologies can be driven by the coevolution of consequential problems and their solution in R&D labs of firms. In general, incumbent and entrant firms have a strong incentive to find innovative solutions to unsolved, consequential and new problems in order to achieve and sustain the prospect of a (temporary) profit monopoly and competitive advantage in markets with technological dynamisms. Overall, then this study shows one of the general sources of disruptive technologies that seems to support industrial and corporate change in a Schumpeterian world of innovation-based competition.